Disseminated cutaneous Fusarium moniliforme infections in a leukemic child

International Journal of Dermatology

Volumn 46, Issue 5, 2007, Pages 487-489

  Chi, Ching Chi ^a   Wang, Shu Hui ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFTAZIDIME; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; MITOXANTRONE;

ACINETOBACTER BAUMANNII; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BLAST CELL; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CAUSE OF DEATH; COUGHING; DERMATOMYCOSIS; DRUG RESPONSE; DRUG WITHDRAWAL; ERYTHEMA; FACE; FAT NECROSIS; FEBRILE NEUTROPENIA; FUNGUS HYPHAE; FUSARIUM MONILIFORME; GRAM NEGATIVE INFECTION; HISTOPATHOLOGY; HUMAN; LEG; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LEUKOCYTOSIS; LUNG INFILTRATE; MALE; NEUTROPENIA; NEUTROPHIL COUNT; PAPULE; PNEUMONIA; PRESCHOOL CHILD; SEPSIS; SKIN BIOPSY; SKIN NODULE; STENOTROPHOMONAS MALTOPHILIA; THORAX RADIOGRAPHY; TREATMENT DURATION;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; DERMATOMYCOSES; FATAL OUTCOME; FUSARIUM; HUMANS; ITRACONAZOLE; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; NEOPLASM RECURRENCE, LOCAL;

EID: 34248206232     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03169.x     Document Type: Article

References (10)

1. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years' experience at a cancer center and implications for management. Blood 1997; 90: 999-1008.
2. Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect 2004; 10 (Suppl. 1): 67-75.
3. Walsh TJ, Groll A, Hiemenz J, et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10 (Suppl. 1): 48-66.
4. Kontoyiannis DP, Bodey GP, Hanna H, et al. Outcome determinants of fusariosis in a tertiary care cancer center: The impact of neutrophil recovery. Leuk Lymphoma 2004; 45: 139-141.
5. Nucci M, Anaissie EJ, Queiroz-Telles F, et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003; 98: 315-319.
6. Consigny S, Dhedin N, Datry A, et al. Successful voriconazole treatment of disseminated Fusarium infection in an immunocompromised patient. Clin Infect Dis 2003; 37: 311-313.
7. Rodriguez CA, Lujan-Zilbermann J, Woodard P, et al. Successful treatment of disseminated fusariosis. Bone Marrow Transplant 2003; 31: 411-412.
8. Walsh TJ, Lutsar I, Driscoll T, et al. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 2002; 21: 240-248.
9. Bigley VH, Duarte RF, Gosling RD, et al. Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole. Bone Marrow Transplant 2004; 34: 815-817.
10. Cudillo L, Girmenia C, Santilli S, et al. Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis. Clin Infect Dis 2005; 40: 1212-1213.